StockWatch
·
Pharmaceutical Preparations
AGM/EGMNov 18, 2026, 05:21 PM

Apimeds Pharmaceuticals Announces 2026 Annual Meeting Details

AI Summary

Apimeds Pharmaceuticals US, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on December 23, 2026. Key proposals include the election of four directors, ratification of Kreit & Chiu CPA LLP as the independent auditor for fiscal year 2026, and approval for the adjournment of the meeting if necessary. The Board of Directors unanimously recommends a vote FOR all proposals. The company also provided details on its executive officers, corporate governance structure, and related party transactions.

Key Highlights

  • Apimeds Pharmaceuticals US, Inc. to hold 2026 Annual Meeting of Stockholders virtually on December 23, 2026.
  • Proposals include election of four directors, ratification of auditor Kreit & Chiu CPA LLP, and adjournment proposal.
  • Board of Directors unanimously recommends a vote FOR all proposals.
  • Record date for voting is November 20, 2026.
  • Proxy materials mailed on or about November 27, 2026.
  • Audit fees for 2025 were $206,933 and for 2024 were $142,918.
  • Notes payable to related parties totaled $500,100 as of December 31, 2025.